Literature DB >> 8298996

Effect of temperature on kainic acid-induced seizures.

Z Liu1, A Gatt, M Mikati, G L Holmes.   

Abstract

The effects of body temperature on kainic acid-induced seizures and seizure-related brain damage were examined in rats. In rats with status epilepticus induced by intraperitoneal injection of 12 mg/kg of kainic acid (KA), ictal discharges were decreased by 50% when body temperature was lowered to 28 degrees C and nearly abolished when body temperature was lowered to 23 degrees C. In rats with mild hypothermia (28 degrees C), the duration of ictal discharges following KA injection was significantly lower than in rats with normal body temperature. No detectable hippocampal cell loss was observed in rats with hypothermia to 28 degrees C whereas gross cell loss in the hippocampus was observed in all rats with KA injection at normal body temperature. In contract to hypothermia, hyperthermia markedly aggravated the seizures and hippocampal damage induced by KA. Following elevation of body temperature to 42 degrees C KA (12 mg/kg) resulted in severe seizures and all rats died of tonic seizures within 2 h. Furthermore, 6 mg/kg of KA administered to rats with a body temperature of 41-42 degrees C, resulted in up to 4 h of continuous ictal discharges whereas no continuous ictal discharges were observed after the same injections in rats with normal body temperature. Histological examination in rats receiving 6 mg/kg of KA revealed severe cell loss in the hippocampus in rats with hyperthermia but not in rats with normal temperature. These results demonstrate that body temperature plays an important role in the control of epileptic seizures and seizure-related brain damage.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298996     DOI: 10.1016/0006-8993(93)91185-u

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Systemic cooling to treat status epilepticus: an old idea becomes a hot topic.

Authors:  John W Miller
Journal:  Epilepsy Curr       Date:  2009 May-Jun       Impact factor: 7.500

Review 2.  Use of hypothermia in the intensive care unit.

Authors:  Jesse J Corry
Journal:  World J Crit Care Med       Date:  2012-08-04

Review 3.  Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors:  Martin Holtkamp
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

4.  Febrile seizures: an appropriate-aged model suitable for long-term studies.

Authors:  T Z Baram; A Gerth; L Schultz
Journal:  Brain Res Dev Brain Res       Date:  1997-02-20

Review 5.  Febrile seizures and mechanisms of epileptogenesis: insights from an animal model.

Authors:  Roland A Bender; Celine Dubé; Tallie Z Baram
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

6.  Alpha-MSH rescues neurons from excitotoxic cell death.

Authors:  Asa Forslin Aronsson; Stefan Spulber; Mircea Oprica; Bengt Winblad; Claes Post; Marianne Schultzberg
Journal:  J Mol Neurosci       Date:  2007-04-17       Impact factor: 3.444

7.  Prevention of hypoglycemia-induced neuronal death by hypothermia.

Authors:  Byung Seop Shin; Seok Joon Won; Byung Hoon Yoo; Tiina M Kauppinen; Sang Won Suh
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-28       Impact factor: 6.200

8.  Hypothermia for refractory status epilepticus.

Authors:  Jesse J Corry; Rajat Dhar; Theresa Murphy; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

9.  Early EEG monitoring for detecting postanoxic status epilepticus during therapeutic hypothermia: a pilot study.

Authors:  Stéphane Legriel; Fabrice Bruneel; Haouaria Sediri; Julia Hilly; Nathalie Abbosh; Matthieu Henry Lagarrigue; Gilles Troche; Pierre Guezennec; Fernando Pico; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

10.  Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and SCN1A mutation: a case report.

Authors:  Steven L Shein; Thomas Q Reynolds; Satyanarayana Gedela; Patrick M Kochanek; Michael J Bell
Journal:  Ther Hypothermia Temp Manag       Date:  2012-09       Impact factor: 1.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.